Blood Tests Revolutionize Women's Cardiovascular Risk Predictions

A new study suggests that assessing women's cardiovascular risks through blood tests in their 30s can predict the risk over the next three decades, challenging the current practice of waiting until after menopause. The findings were presented at the European Society of Cardiology meeting in London.

In a groundbreaking revelation, researchers have found that simple blood tests can estimate women's cardiovascular disease risks up to 30 years in advance. The study advocates for earlier evaluations, particularly in women in their 30s, a shift from the traditional approach that begins post-menopause.

Presented at the European Society of Cardiology annual meeting in London, the study underscores the urgency of rethinking preventive strategies. "Our findings could transform the timeline for when women start taking preventive medications," said the researchers.

This pioneering research marks the first instance where blood tests have been proven effective in long-term cardio risk prediction for women, potentially leading to significant changes in early preventive measures and healthcare policies.

(With inputs from agencies.)